Riding the wave of the global weight-loss drug phenomenon, Irish nutrition company Glanbia has hiked its profit forecast, signaling robust demand for protein products across all three of its nutrition divisions.

The unexpected surge reflects how breakthrough medications like GLP-1 drugs are reshaping consumer behavior and creating unexpected winners in the food and wellness sector. As more people pursue healthier lifestyles with pharmaceutical support, protein-rich products have become essential pantry staples. Read the full story →

Today's takeaway: Innovation in medicine is creating real business opportunities for companies positioned to meet shifting consumer needs.